ALL 8 Memorial Sloan Kettering Cancer... - Advanced Prostate...

Advanced Prostate Cancer

21,609 members27,064 posts

ALL 8 Memorial Sloan Kettering Cancer Center PCa nomograms

maley2711 profile image
0 Replies

Since there seemed to be some uncertainty as to what I had shared on a previous post, here are all 8 PCa nomograms and the explanations for each.......

mskcc.org/nomograms/prostate

(1) Our pre-radical prostatectomy nomogram is for patients diagnosed with prostate cancer who have not yet begun treatment. This nomogram predicts the extent of the cancer and long-term results following radical prostatectomy (surgery to remove the prostate gland and surrounding lymph nodes). Using a dynamic statistical formula, this nomogram draws on data from more than 10,000 prostate cancer patients treated at MSK.

mskcc.org/nomograms/prostat...

(2) Our post-radical prostatectomy nomogram can be used by patients after their surgical treatment for prostate cancer. Using a dynamic statistical formula, this nomogram predicts the probability of remaining cancer recurrence-free at two, five, seven, and ten years following surgery. This nomogram also predicts 15-year cancer-specific survival, meaning the likelihood that you will NOT die of prostate cancer within 15 years following surgery.

mskcc.org/nomograms/prostat...

(3) Our salvage radiation therapy nomogram predicts whether a recurrence of prostate cancer after radical prostatectomy can be treated successfully with salvage radiation therapy (external-beam radiation given after the prostate cancer returns). It calculates the probability that the cancer will be controlled and PSA level undetectable six years after salvage therapy. You can use this nomogram for applicable results if your post-radical prostatectomy serum PSA level was at first undetectable (less than 0.05 ng/mL) and then rose steadily, indicating a recurrence.

mskcc.org/nomograms/prostat...

(4) This nomogram can be used by patients to estimate the risk of dying of prostate cancer if their cancer recurs, signaled by a rising PSA, after radical prostatectomy. The nomogram predicts the likelihood, in a man initially treated with surgery, that he will die of prostate cancer five, ten, and 15 years from the time his PSA begins to rise.

mskcc.org/nomograms/prostat...

(5) This tool is designed to calculate the likelihood of having high-grade prostate cancer in men who have been considered eligible for prostate biopsy by a urologist. If you have not been examined by a urologist, the results produced by this calculator will be a considerable overestimation of your risk for prostate cancer (that is, it will give a risk that is too high). This tool is not applicable for men who have already been diagnosed with prostate cancer.

mskcc.org/nomograms/prostat...

(6) Using inputs of current age and race, this tool calculates average life expectancy, which can be used for comparison when considering the survival probabilities of various treatment options.

webcore.mskcc.org/survey/su......

(7) This tool calculates prostate tumor volume.

mskcc.org/nomograms/prostat...

(8) This tool can be used to calculate the rate of rise of PSA, expressed as the velocity in nanograms/mL/year, or the PSA doubling time, in months or years.

mskcc.org/nomograms/prostat...

Written by
maley2711 profile image
maley2711
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

List of drugs by their metastatic prostate cancer cancer fighting properties

I asked ChatGPT to put the following drugs in order of their metastatic prostate cancer cancer...

A technical question on Radiation

A technical question: The radiation oncologist tells me that I received 19.5 Gy via Cyberknife...

Introduction and asking for help interpreting latest scan results and thoughts on future treatment plan please.

Long time reader but first time posting.. I have just received my latest PSMA PET-CT scan results...

radiation treatments led to perforated colon?

St. Patrick’s Day I collapsed in pain and was rushed to ER. A CT ABD PE revealed a perforated colon...

Syncromune Granted FDA Fast-Track Designation for SYNC-T SV-102 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

FORT LAUDERDALE, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage...